Drug Enforcement Administration October 27, 2015 – Federal Register Recent Federal Regulation Documents

Schedules of Controlled Substances: Table of Excluded Nonnarcotic Products: Vicks® VapoInhaler®
Document Number: 2015-27266
Type: Rule
Date: 2015-10-27
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is amending the table of Excluded Nonnarcotic Products to update the listing for Vicks[supreg] VapoInhaler[supreg], containing 50 mg levmetamfetamine in a nasal decongestant inhaler, marketed by The Proctor & Gamble Company. This over-the-counter, non-narcotic drug product is excluded from provisions of the Controlled Substances Act.
Schedules of Controlled Substances: Table of Excluded Nonnarcotic Products: Nasal Decongestant Inhaler/Vapor Inhaler
Document Number: 2015-27264
Type: Rule
Date: 2015-10-27
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration is amending the table of Excluded Nonnarcotic Products to update the company name for the drug product Nasal Decongestant Inhaler/Vapor Inhaler (containing 50 milligrams levmetamfetamine) to Aphena Pharma SolutionsNew York, LLC. This over-the-counter, nonnarcotic drug product is excluded from the provisions of the Controlled Substances Act.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.